Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.662
-0.078 (-4.48%)
Jan 16, 2026, 4:00 PM EST
Positron Market Cap
Positron has a market cap or net worth of $54.41 million as of January 20, 2026. Its market cap has increased by 102.04% in one year.
Market Cap
54.41M
Enterprise Value
54.55M
Revenue
486.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.66
Market Cap Chart
Since December 3, 1993, Positron's market cap has increased from 22.73M to 54.41M, an increase of 139.37%. That is a compound annual growth rate of 2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 54.41M | -0.48% |
| Dec 31, 2025 | 54.67M | 98.24% |
| Dec 30, 2024 | 27.58M | -29.54% |
| Dec 29, 2023 | 39.14M | 88.62% |
| Dec 29, 2022 | 20.75M | -34.40% |
| Dec 31, 2021 | 31.63M | 1,169.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |